The 3D cell culture market has been on a strong and sustained growth trajectory, driven primarily by the pharmaceutical and biotechnology industries. Now, a regulatory shift is poised to further amplify that momentum. The FDA…

Since the FDA and NIH signaled their pivot toward New Approach Methodologies (NAMs) early last year, the most meaningful developments have been in how quickly those signals have turned into practical pathways. FDA’s 2025 roadmap…

The U.S. diagnostic imaging market is valued at approximately $150 billion in 2025 and encompasses an estimated 600 million or more procedures annually. But where a scan is performed matters enormously — for the patient’s…

The diagnostic imaging industry is continuing to see significant technological innovation. Across CT, MRI, and ultrasound, OEMs are bringing innovations to market that don’t just improve image quality — they have the potential to change…

Artificial intelligence (AI)is no longer speculative in the life sciences. It is embedded in tools, workflows, and daily research activities across academia, industry, and government labs. Yet as AI usage expands in 2026, a clear…